Access cutting-edge ewing sarcoma treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access ewing sarcoma specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ewing sarcoma treatment provided free
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.
Sponsor: Children's Hospital of Philadelphia
Check if you qualify for this ewing sarcoma clinical trial in Philadelphia, PA
If you're searching for ewing sarcoma treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ewing sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.